Healthcare & the Longevity Economy: Major Trends & Opportunities

The evolving landscape of healthcare, increasingly crucial in the face of diverse health challenges, is the focal point of this conference panel. We aim to unravel the pivotal trends in healthcare and deliberate on their future impact.

Personalized Medicine:
By harnessing the power of genomic and proteomic technologies, treatments are becoming tailored to genetic profiles. Our expert panel will delve into the implications of this personalization on healthcare results and the hurdles in large-scale application.

Digital Health:
The advent of wearables, mobile health apps, and telemedicine are altering healthcare delivery dynamics. We will investigate the pros and cons, along with the ethical and regulatory concerns, of this digital shift.

AI and Machine Learning:
AI and machine learning hold promise in revolutionizing healthcare, enhancing diagnostics, treatments, and results. Our discussion will cover the latest breakthroughs and their potential effects on the healthcare workforce.

Preventive Healthcare:
As a cost-saving, health-optimizing strategy, preventive healthcare has garnered focus. The panel will address the challenges and prospects in advancing preventive healthcare, involving public awareness and policy incentives.

The future of health is a thrilling, fast-paced domain with ceaseless innovations. Through dissecting core themes—personalized medicine, digital health, AI and machine learning, and preventive healthcare—this panel aspires to shed light on the trials and triumphs in shaping tomorrow’s healthcare.

MODERATOR:

Rosemarie Truman
Growth Strategy | Entrepreneur | Startup Catalyst | Impact Investor | Corporate Executive
Entrepreneur, startup catalyst, impact investor and a corporate executive. Founder and CEO of The Center for Advancing Innovation Inc. CEO and Co-Founder of Ignite Social Impact, the first crowd platform to democratize impact investing. Read full profile…

PANEL:

Valerie Fremont, Ph.D.
Quality Biological CSO/VP Market Development & Strategy
Valerie Fremont, Ph.D. has expertise in R&D and Drug Discovery, with a strong background in biochemistry, protein engineering, molecular biology, cell culture and neurobiology for the development and production of new recombinant protein therapeutics. Dr. Fremont’s expertise covers all early stages of the drug development process until late R&D and preclinical evaluation. Read full profile…

Jarrod Borkat
CareDx SVP, Head of Marketing & Portfolio Operations
Seasoned and accomplished pharmaceutical and biotech leader, with strong partnering, corporate strategy, portfolio management, sales and marketing background. Experience in managing U.S. and global marketing franchises and marketing teams in multiple disease categories. Wide breath of pipeline and in-line expertise, including strategic planning, portfolio management, corporate goal setting, direct-to-consumer advertising, PR, marketing research, healthcare professional promotion, product launches, lifecycle management and managed markets. Read full profile…

John Bittman
NIST Interagency Policy Specialist, Technology Partnerships Office (TPO)
John Bittman is an Interagency Policy Specialist in the Technology Partnerships Office (TPO) at the National Institute of Standards and Technology (NIST). He works on convening technology transfer stakeholders and assisting in program and policy formulation on behalf of the interagency technology transfer community. Read full profile…

(Colonel) Matt Clark
CBRN Medical Joint Project Manager, JPEO-CBRND
Colonel Matt Clark is the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical). He leads the medical research, development and acquisition portfolio within the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND). Read full profile…

Carol Nacy, Ph.D
CEO, Sequella, Inc.
Dr. Carol A. Nacy presently is Chairman & Chief Executive Officer at this company. Dr. Nacy is also on the board of NuGenerex Immuno-Oncology, Inc. and Member of American Academy of Microbiology. Dr. Nacy previously occupied the position of President of American Society for Microbiology and Chairman of the Board at ASM Resources, Inc. (a subsidiary of American Society for Microbiology), Chief Scientific Officer of Anergen, Inc. and Chief Scientific Office & Executive Vice President at CASI Pharmaceuticals, Inc. Read full profile…